NVR

[Pharmaceutical products, namely, Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals;] Cardiovascular pharmaceuticals;[ Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; ]Pharmaceutical preparations acting on the central nervous system;[ Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;] Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system,[ the musculo-skeletal system and the genitourinary system;] pharmaceutical preparations for use in hematology and in tissue and organ transplantation; [Pharmaceutical preparations for the treatment of eye diseases and conditions; ]Pharmaceutical preparations for the treatment of heart rhythm disorders;[ Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes;] Pharmaceutical preparations for treating hypertension;[ Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; ]Pharmaceutical products for the prevention and treatment of cancer[; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma]